Hospital-acquired Bacterial Pneumonia
9 clinical trials · Condition
◉ Watch Hospital-acquired Bacterial Pneumonia
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex (NCT03894046) | Entasis Therapeutics | 2019-09-05 |
| Telavancin Observational Use Registry (TOUR) (NCT02288234) | Cumberland Pharmaceuticals | 2014-11-01 |
| Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults (NCT02168946) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2014-07-01 |
| Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae (NCT02420366) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2014-05-01 |
Track Hospital-acquired Bacterial Pneumonia automatically
Every clearance here is in the API, with alerts when new ones post.